Healthcare Equipment and Supplies
Company Overview of Respironics Inc.
As of March 13, 2008, Respironics Inc. was acquired by Philips Holding USA Inc. Respironics, Inc. develops, manufactures, and distributes products for sleep and respiratory markets. It offers non-invasive ventilation systems, homecare pulse oximetry systems, oxygen concentrators, portable home ventilators, CPAP and BiPAP therapy devices, masks, diagnostic sleep systems, titration systems, screening devices, oral appliances, peak flow meters, spacer/holding chambers, nebulizers and compressors, and allergy products. The company offers its products through online. Respironics, Inc. was founded in 1976 and is headquartered in Murrysville, Pennsylvania. It has locations in Murrysville and Youngw...
1010 Murry Ridge Lane
Murrysville, PA 15668-8525
Founded in 1976
Key Executives for Respironics Inc.
Respironics Inc. does not have any Key Executives recorded.
Respironics Inc. Key Developments
Respironics, Inc. Response to ResMed Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy
May 16 15
Respironics Inc. provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea and Chronic Heart Failure. On May 13, 2015, ResMed issued a release and a related Urgent Field Safety Notice. This report described a statistically significant 2.5% absolute increased annual risk of cardiovascular mortality for those randomized to a ResMed adaptive servo ventilation (ASV) therapy compared to the control group. In the patient population with LVEF = 45%, 10.0% of the ASV group experienced a cardiovascular death each year compared to 7.5% of the control group, representing a 33.5% relative increased risk of cardiovascular mortality (HR=1.335, 95%CI=(1.070, 1.666), p-value= 0.010). Philips Respironics BiPAP autoSV/BiPAP autoSV Advanced devices are currently indicated to provide non-invasive ventilatory support to adult patients (>30 kg/66 lbs.) with obstructive sleep apnea and respiratory insufficiency caused by central and/or mixed apneas and periodic breathing. These devices are not approved or labeled for the treatment of heart failure.
Philips Respironics Announces Worldwide Recall of Approximately 600 Philips Respironics Trilogy Ventilators
Feb 19 14
Respironics Inc. announced a worldwide recall of approximately 600 Philips Respironics Trilogy Ventilators, comprising Trilogy Ventilator Models 100, 200 and 202. On February 11, 2014, Philips Respironics initiated a voluntary recall to address a potentially defective component on the Trilogy Ventilator power management board, which could affect the function of the device. If this issue is not corrected it is possible that the ventilator may fail to deliver mechanical breaths and that the alarm functionality may be reduced to indicate ventilatory failure, resulting in serious adverse health consequences or death. There have been no reports of death or serious injury related to this potential problem. The Philips Respironics Trilogy Ventilator is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation. The devices are intended to be used in home, institution/hospital, and portable applications such as wheelchairs and gurneys. During production testing Philips Respironics discovered that the Trilogy ventilators contain a potentially defective ferrite component on the power management board of the device. This recall affects 600 Trilogy Ventilator devices shipped between December 31, 2013, and January 30, 2014. Philips Respironics is instructing customers to remove affected devices from service and to return them to Philips for replacement. All distributors, providers, and customers with potentially affected Trilogy devices will have their units replaced. Philips Respironics has notified all United States and international distributors, providers, and customers that may have devices subject to this recall, and has provided affected device serial numbers for identification. Serial numbers of affected devices are located on the back of the device, as indicated in the accompanying product image. Countries where affected devices have been shipped include the United States, France, United Kingdom, Hong Kong, India, Italy, Korea, Kuwait, Netherlands, and Singapore.
Philips Respironics Launches Minimal Contact Nasal Mask
Jul 12 13
Philips Respironics has launched new minimal contact nasal mask, Wisp. Designed to fit more than 98% of sleep apnea patients, Wisp brings distinctive styling and patented technology for a better overall mask experience that may improve patient compliance. A departure from traditional masks, Wisp
combines the performance and comfort of a nasal mask with the aesthetic of a pillows mask to deliver best in class performance in four areas: comfort, ease of use, visual appeal, and the ability to fit a wide range of patients. Compact and lightweight, Wisp offers a minimal contact experience, a superior seal and an open field of vision. Patients can read and even wear their glasses.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|